Robert Jahr
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Robert Charles Jahr is President, Chief Executive Officer & Director at Outlook Therapeutics, Inc. since 2025.
Formerly, Mr. Jahr was Chief Commercial Officer at Sobi North America in 2025 and Vice President & Head-International Markets at UCB Pharma SA. Education includes undergraduate and MBA degrees from the University of Montana System.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-05-2026 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| OUTLOOK THERAPEUTICS, INC. | Algemeen Directeur | 01-07-2025 |
| Bedrijven | Functie | Einde |
|---|---|---|
UCB Pharma SA
UCB Pharma SA Chemicals: SpecialtyProcess Industries Manufactures pharmaceutical products | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
UCB Pharma SA
UCB Pharma SA Chemicals: SpecialtyProcess Industries Manufactures pharmaceutical products | Process Industries |
University of Montana System
University of Montana System Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Outlook Therapeutics, Inc.
Outlook Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Manufactures bevacizumab therapeutic products | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau